Neovasc Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
64065J304
SEDOL
N/A
CIK
0001399708
www.neovasc.com
LEI:
©
New: Infographics X-Lab
FIGI: BBG00JQB36G1
NVCN
Neovasc Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Medical Devices
AI
PROFILER
NAME
Neovasc Inc.
ISIN
CA64065J3047
TICKER
NVCN
MIC
XNAS
REUTERS
NVCN.OQ
BLOOMBERG
NVCN US
F&G: 75
1,36918 USDCAD · 118.562,61 BTC · 17,28 Vola-Index · 22.773,43 Tech100
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von Newsfile Corp. bereitgestellt.
Di., 26.07.2022       Neovasc
CA64065J3047

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 26, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced the United States Food and Drug Administration ("FDA") has approved a protocol supplement to the COSIRA-II Investigational Device Exemption ("IDE") Trial. The approval expan...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Di., 05.07.2022       Neovasc
CA64065J3047

Expansion Driven by NICE Guidelines and Enhanced Reimbursement for the Neovasc Reducer(TM)Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 5, 2022) - Neovasc, Inc. (NASDAQ: NVCN)  (TSX: NVCN) ("Neovasc" or the "Company") today announced that the company has expanded its direct sales operations in Europe ...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Mi., 08.06.2022       Neovasc
CA64065J3047

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 8, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced that its management team will be participating in the 2022 Sidoti & Co. Summer Small Cap Virtual Investor Conference to be held June 15-16, 2022. Neovasc's Chief ...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Mo., 23.05.2022       Neovasc
CA64065J3047

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 23, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced that its management team will be participating in the H.C. Wainwright Global Investment Conference to be held May 23-26, 2022. Fred Colen, Neovasc's President and Chief Executiv...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Mo., 16.05.2022       Neovasc
CA64065J3047

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 16, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received written notification from the Nasdaq Stock Market LLC (the "Nasdaq") informing the Company that it has regained compliance with the minimum bid price requ...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Do., 12.05.2022       Neovasc
CA64065J3047

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 12, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today reported financial results for the quarter ended March 31, 2022.Recent HighlightsAchieved Q1 revenue of approximately $611,000, an increase of 35% over the same period in 2021, deliveri...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Fr., 29.04.2022       Neovasc
CA64065J3047

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 29, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the quarter ended March 31, 2022 on Thursday, May 12, 2022. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, Chief Financial Officer, will host a conf...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Do., 28.04.2022       Neovasc
CA64065J3047

Report demonstrates objective improvements in patients suffering from microvascular dysfunctionVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 28, 2022) - Neovasc, Inc. (NASDAQ: NVCN) TSX: NVCN) ("Neovasc" or the "Company") today announced that the European Heart Journal has published an article entitled, "...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Mi., 27.04.2022       Neovasc
CA64065J3047

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the treatment of refractory angina, and in the development of minimally invasive transcatheter mitral valve replacement technologies, announced today tha...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
Mi., 20.04.2022       Neovasc
CA64065J3047

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 20, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX : NVCN) (Neovasc or the Company) today announced that its management team will be participating in the 2022 Bloom Burton & Co. Healthcare Investment Conference to be held May 2-3, 2022. Fred Colen, Ne...
Zur Nachricht
Neovasc
Technische Analyse Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S